Melissa Hall​ looks at the implications of a data breach at the UK Biobank ...

Moderna (NasdaqGS:MRNA) has expanded its collaboration with CEPI to accelerate development of an mRNA vaccine targeting ...

Republican businessman Zach Lahn pulled off an upset victory, defeating U.S. Rep. Randy Feenstra for the Iowa Republican ...

A chronic lack of investment in development of better tests has left clinicians blind and allows deadly viruses to spread ...

AbbVie holds a Moderate Buy consensus from 19 Wall Street analysts, including zero Sell recommendations and a mean price ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more therapies or technologies that, if effective, could improve treatments ...

The WHO declared Ebola a Public Health Emergency of International Concern due to the Bundibugyo strain.

As governments and health authorities rush to meet the moment of a worsening Ebola outbreak in central Africa, Merck & Co. is considering dusting off its antiviral molnupiravir, which saw use as a ...

Emphasizes Importance of Experienced Biotech Leadership as Vaxart AdvancesClinical and Strategic Priorities with Multiple Value-Creating ...

The animal rights group argues the Washington Metropolitan Area Transit Authority is “hell-bent” on preventing any of its ads ...

The 2026 epidemic of Ebola virus disease caused by Bundibugyo virus (species Orthoebolavirus bundibugyoense) in DR Congo and Uganda has been declared a public health emergency of international concern ...

Sanofi's Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector Sarclisa administered via the CirCLIQ OBI offers a treatment experience designe ...